The protective effect of infliximab against carbon tetrachloride-induced acute lung injury
Göster/ Aç
Erişim
info:eu-repo/semantics/openAccessTarih
2016Yazar
Kurt, AyselTümkaya, Levent
Yüce, Süleyman
Türüt, Hasan
Cüre, Medine Cumhur
Şehitoğlu, İbrahim
Kalkan, Yıldıray
Pusuroğlu, Gökhan
Cüre, Erkan
Üst veri
Tüm öğe kaydını gösterKünye
Kurt, A., Tumkaya, L., Yuce, S., Turut, H., Cure, M. C., Sehitoglu, I., Kalkan, Y., Pusuroglu, G., & Cure, E. (2016). The protective effect of infliximab against carbon tetrachloride-induced acute lung injury. Iranian journal of basic medical sciences, 19(6), 685–691.Özet
Objective(s): Carbon tetrachloride (CCl4) causes pulmonary toxicity. Infliximab (Ib) is a potent inhibitor of tumor necrosis factor-alpha (TNF-alpha). We aimed to investigate whether Ib has a protective effect on CCl4 induced lung injury. Materials and Methods: Rats were divided into control, CCl4, and CCl4+Ib groups. A single dose of 2 ml/kg CCI4 was administered to CCI4 group and a single dose of 7 mg/kg Ib was given to CCl4+Ib group 24 hr before applying CCI4. Results: TNF-alpha, malondialdehyde (MDA), nitric oxide (NO) and caspase-3 levels of the CCl4 group were markedly higher than both the control and CCl4+Ib groups. the CCI4+Ib group had lower histopathological injury than the CCl4 group. Conclusion: Ib as a strong TNF-alpha blocker decreases the production of proinflammatory cytokines, MDA, and oxidative stress leading to a protective effect against CCl4 induced lung tissue injury.